Traditional biologics, new biotherapeutics modalities and biosimilars are flooding discovery and development pipelines. Thus, analytical function is rapidly evolving, demanding high-throughput and high-resolution tools, focused biomolecular and biophysical assays, rapid analytical and impurity profiling strategies, and optimized bioprocess operations achieved through cutting-edge data analytics. The Analytics & Impurities pipeline features in-depth perspectives on the most critical steps in characterization of biologics, stability issues arising from particles, impurities, processes and effective tools and strategies for data analysis and interpretation.

Conferences Include:

January 8-9

Characterization of Biotherapeutics

January 9-10

Detection and Characterization of Particulates and Impurities